Skeletal effects of carcinoma of the breast and prostate
- PMID: 3789624
- PMCID: PMC2498336
Skeletal effects of carcinoma of the breast and prostate
Abstract
Recent research has led to improved understanding of the pathology of skeletal metastases in carcinoma of the breast and prostate. Several humoral mechanisms have been identified which have both primary and secondary consequences on skeletal metabolism and probably depend on the complex interplay of a number of factors derived from tumour tissues. An improved understanding of these interactions may lead to new approaches in the management of these common disorders.
Similar articles
-
Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.Cancer Treat Rev. 2000 Feb;26(1):11-27. doi: 10.1053/ctrv.1999.0143. Cancer Treat Rev. 2000. PMID: 10660489 Review.
-
The development and function of the skeleton and bone metastases.Cancer. 2003 Feb 1;97(3 Suppl):726-32. doi: 10.1002/cncr.11147. Cancer. 2003. PMID: 12548569 Review.
-
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.Calcif Tissue Int. 2007 Nov;81(5):341-51. doi: 10.1007/s00223-007-9061-x. Epub 2007 Sep 18. Calcif Tissue Int. 2007. PMID: 17874331 Clinical Trial.
-
[Biphosphonates in the treatment of bone metastasis of prostatic cancer].Prog Urol. 2001 Dec;11(6):1205-12. Prog Urol. 2001. PMID: 11859653 Review. French.
-
Bone metastases in breast cancer, prostate cancer and myeloma.Bone. 1987;8 Suppl 1:S17-22. Bone. 1987. PMID: 3318889 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical